238 related articles for article (PubMed ID: 19119958)
1. Development of an intramuscular xenograft model of canine osteosarcoma in mice for evaluation of the effects of radiation therapy.
Coomer AR; Farese JP; Milner R; Taylor D; Salute ME; Rajon DA; Bova FJ; Siemann DW
Am J Vet Res; 2009 Jan; 70(1):127-33. PubMed ID: 19119958
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of canine osteosarcoma cell lines that induce transplantable tumors in nude mice.
Nieves MA; Vahle J; Ackermann M; Howard M; Dietz AB; Carpenter SL; Cheville N
Am J Vet Res; 1998 Mar; 59(3):359-62. PubMed ID: 9522958
[TBL] [Abstract][Full Text] [Related]
3. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
Shoieb AM; Hahn KA; Barnhill MA
In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines.
Fitzpatrick CL; Farese JP; Milner RJ; Salute ME; Rajon DA; Morris CG; Bova FJ; Lurie DM; Siemann DW
Am J Vet Res; 2008 Sep; 69(9):1197-202. PubMed ID: 18764694
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice.
Berlin O; Samid D; Donthineni-Rao R; Akeson W; Amiel D; Woods VL
Cancer Res; 1993 Oct; 53(20):4890-5. PubMed ID: 8402677
[TBL] [Abstract][Full Text] [Related]
6. A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo.
Comstock KE; Hall CL; Daignault S; Mandlebaum SA; Yu C; Keller ET
In Vivo; 2009; 23(5):661-8. PubMed ID: 19779098
[TBL] [Abstract][Full Text] [Related]
7. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic treatment of xenograft Spirocerca lupi-associated sarcoma in a murine model.
Stettner N; Ranen E; Dank G; Lavy E; Brenner O; Harmelin A
Comp Med; 2007 Jun; 57(3):267-71. PubMed ID: 17605341
[TBL] [Abstract][Full Text] [Related]
9. Effect of bevacizumab on angiogenesis and growth of canine osteosarcoma cells xenografted in athymic mice.
Scharf VF; Farese JP; Coomer AR; Milner RJ; Taylor DP; Salute ME; Chang MN; Neal D; Siemann DW
Am J Vet Res; 2013 May; 74(5):771-8. PubMed ID: 23627391
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis following radiation therapy and/or chemotherapy for canine osteosarcoma.
Withrow SJ; Powers BE; Straw RC; Thrall DE; Gillette EL; LaRue SM; Richter SL
Chir Organi Mov; 1990; 75(1 Suppl):29-31. PubMed ID: 2249550
[No Abstract] [Full Text] [Related]
11. A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma.
Wang LF; Zhou Y; Xu YM; Qiu XC; Zhou BG; Wang F; Long H; Chen X; Yang TT; Ma BA; Fan QY; Yang AG
Cancer Invest; 2009 Aug; 27(7):774-80. PubMed ID: 19488908
[TBL] [Abstract][Full Text] [Related]
12. Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.
Marini P; Budach W; Niyazi M; Junginger D; Stickl S; Jendrossek V; Belka C
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):198-202. PubMed ID: 19695436
[TBL] [Abstract][Full Text] [Related]
13. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
14. Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft.
Sottnik JL; Hansen RJ; Gustafson DL; Dow SW; Thamm DH
Vet Comp Oncol; 2011 Jun; 9(2):118-30. PubMed ID: 21569197
[TBL] [Abstract][Full Text] [Related]
15. Orthotopic model of canine osteosarcoma in athymic rats for evaluation of stereotactic radiotherapy.
Schwartz AL; Custis JT; Harmon JF; Powers BE; Chubb LS; LaRue SM; Ehrhart NP; Ryan SD
Am J Vet Res; 2013 Mar; 74(3):452-8. PubMed ID: 23438123
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo.
Goupil RC; Bushey JJ; Peters-Kennedy J; Wakshlag JJ
Vet Pathol; 2012 Sep; 49(5):802-10. PubMed ID: 22287649
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of two different methods for establishing nude mouse model bearing osteosarcoma].
Guan MQ; Shi ZJ; Li P; Yang LB
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):1960-3. PubMed ID: 19033102
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for canine appendicular osteosarcoma.
Coomer A; Farese J; Milner R; Liptak J; Bacon N; Lurie D
Vet Comp Oncol; 2009 Mar; 7(1):15-27. PubMed ID: 19222827
[TBL] [Abstract][Full Text] [Related]
19. Characterization of osteosarcoma cells from two sibling large-breed dogs.
Norrdin RW; Powers BE; Torgersen JL; Smith RE; Withrow SJ
Am J Vet Res; 1989 Nov; 50(11):1971-5. PubMed ID: 2619126
[TBL] [Abstract][Full Text] [Related]
20. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation.
Kirpensteijn J; Teske E; Kik M; Klenner T; Rutteman GR
Anticancer Res; 2002; 22(5):2765-70. PubMed ID: 12529994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
